-transparent.png){kind=logo}
Midpoint reduction potentials for the flavin cofactors in the reductase domain of rat neuronal nitric oxide synthase (nNOS) in calmodulin (CaM)-free and -bound forms have been determined by direct anaerobic titration. In the CaM-free form, the FMN potentials are -49 +/- 5 mV (oxidized/semiquinone) -274 +/- 5 mV (semiquinone/reduced). The corresponding FAD potentials are -232 +/- 7, and -280 +/- 6 mV. The data indicate that each flavin can exist as a blue (neutral) semiquinone. The accumulation of blue semiquinone on the FMN is considerably higher than seen on the FAD due to the much larger separation (225 mV) of its two potentials (cf. 48 mV for FAD). For the CaM-bound form of the protein, the midpoint potentials are essentially identical: there is a small alteration in the FMN oxidized/semiquinone potential (-30 +/- 4 mV); the other three potentials are unaffected. The heme midpoint potentials for nNOS [-239 mV, L-Arg-free; -220 mV, L-Arg-bound; Presta, A., Weber-Main, A. M., Stankovich, M. T., and Stuehr, D. J. (1998) J. Am. Chem. Soc. 120, 9460-9465] are poised such that electron transfer from flavin domain is thermodynamically feasible. Clearly, CaM binding is necessary in eliciting conformational changes that enhance flavin to flavin and flavin to heme electron transfers rather than causing a change in the driving force.
M A Noble, and
A W Munro, and
S L Rivers, and
L Robledo, and
S N Daff, and
L J Yellowlees, and
T Shimizu, and
I Sagami, and
J G Guillemette, and
S K Chapman
May 1995,
Biochemistry and molecular biology international,
M A Noble, and
A W Munro, and
S L Rivers, and
L Robledo, and
S N Daff, and
L J Yellowlees, and
T Shimizu, and
I Sagami, and
J G Guillemette, and
S K Chapman
August 2004,
Biochemistry,
M A Noble, and
A W Munro, and
S L Rivers, and
L Robledo, and
S N Daff, and
L J Yellowlees, and
T Shimizu, and
I Sagami, and
J G Guillemette, and
S K Chapman
March 2009,
The journal of physical chemistry. B,
M A Noble, and
A W Munro, and
S L Rivers, and
L Robledo, and
S N Daff, and
L J Yellowlees, and
T Shimizu, and
I Sagami, and
J G Guillemette, and
S K Chapman
January 1996,
Methods in enzymology,
M A Noble, and
A W Munro, and
S L Rivers, and
L Robledo, and
S N Daff, and
L J Yellowlees, and
T Shimizu, and
I Sagami, and
J G Guillemette, and
S K Chapman
December 1999,
Biochimica et biophysica acta,
M A Noble, and
A W Munro, and
S L Rivers, and
L Robledo, and
S N Daff, and
L J Yellowlees, and
T Shimizu, and
I Sagami, and
J G Guillemette, and
S K Chapman
April 2003,
Archives of biochemistry and biophysics,
M A Noble, and
A W Munro, and
S L Rivers, and
L Robledo, and
S N Daff, and
L J Yellowlees, and
T Shimizu, and
I Sagami, and
J G Guillemette, and
S K Chapman
July 2009,
Journal of medicinal chemistry,
M A Noble, and
A W Munro, and
S L Rivers, and
L Robledo, and
S N Daff, and
L J Yellowlees, and
T Shimizu, and
I Sagami, and
J G Guillemette, and
S K Chapman
April 2001,
Nitric oxide : biology and chemistry,
M A Noble, and
A W Munro, and
S L Rivers, and
L Robledo, and
S N Daff, and
L J Yellowlees, and
T Shimizu, and
I Sagami, and
J G Guillemette, and
S K Chapman
August 2003,
The Journal of biological chemistry,
M A Noble, and
A W Munro, and
S L Rivers, and
L Robledo, and
S N Daff, and
L J Yellowlees, and
T Shimizu, and
I Sagami, and
J G Guillemette, and
S K Chapman
August 1998,
Proceedings of the National Academy of Sciences of the United States of America,
